Varex Imaging (VREX) Total Non-Current Liabilities (2016 - 2026)
Varex Imaging (VREX) reported Total Non-Current Liabilities of $553.1 million for Q2 2026, down 26.66% year-over-year from $754.2 million in Q2 2025, and down 0.88% quarter-over-quarter from $558.0 million in Q1 2026.
Varex Imaging (VREX) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Total Non-Current Liabilities data on file, last reported at $553.1 million in Q2 2026.
- Total Non-Current Liabilities for Q2 2026 came in at $553.1 million, down 26.66% year-over-year; the trailing twelve-month figure through Apr 2026 was $553.1 million (down 26.66% YoY), and the FY2025 annual result was $582.7 million, down 6.02% from the prior year.
- Total Non-Current Liabilities eased to $553.1 million in Q2 2026 per VREX's latest filing, from $558.0 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $754.2 million in Q2 2025 and troughed at $553.1 million in Q2 2026.
- A 5-year average of $617.7 million and a median of $614.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities gained 21.76% in 2025, then retreated 26.66% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $616.1 million in 2022, then dropped by 0.28% to $614.4 million in 2023, then gained by 0.91% to $620.0 million in 2024, then fell by 6.02% to $582.7 million in 2025, then declined by 5.08% to $553.1 million in 2026.
- Business Quant data shows VREX's Total Non-Current Liabilities at $553.1 million in Q2 2026, $558.0 million in Q1 2026, and $582.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Varex Imaging | 441.84 Mn | 367.44 Mn | 72.60 Mn | 553.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 553.10 Mn |
| Jan 2, 2026 | 558.00 Mn |
| Oct 3, 2025 | 582.70 Mn |
| Jul 4, 2025 | 564.70 Mn |
| Apr 4, 2025 | 754.20 Mn |
| Jan 3, 2025 | 737.50 Mn |
| Sep 27, 2024 | 620.00 Mn |
| Jun 28, 2024 | 614.30 Mn |
| Mar 29, 2024 | 619.40 Mn |
| Dec 29, 2023 | 614.40 Mn |
| Sep 29, 2023 | 627.00 Mn |
| Jun 30, 2023 | 623.10 Mn |
| Mar 31, 2023 | 615.30 Mn |
| Dec 30, 2022 | 616.10 Mn |
| Sep 30, 2022 | 603.90 Mn |
| Jul 1, 2022 | 602.60 Mn |
| Apr 1, 2022 | 594.50 Mn |
| Dec 31, 2021 | 600.90 Mn |
| Oct 1, 2021 | 619.20 Mn |
| Jul 2, 2021 | 640.90 Mn |